Broadcom and Apple extend custom chip partnership through 2031

Broadcom has agreed to extend and expand its partnership with Apple for the development and supply of custom chips through 2031, according to multiple reports published on July 6, 2026.

The announcement, as described by market coverage, keeps Broadcom in a central role for Apple’s supply of application-specific silicon that is designed around Apple’s own architectures rather than off-the-shelf processors. Such custom chips, often produced as application-specific integrated circuits (ASICs), are used to improve performance and power efficiency for specific device functions, from connectivity to machine-learning workloads.

While Apple’s processor strategy has often centered on its own chip designs, the practical reality for most consumer products is that Apple must secure manufacturing capacity and specialized component supply over long horizons. Extending a chip supply and development agreement reduces the risk that Apple would need to re-source critical silicon if the original term approached its end.

The Reuters report and other secondary coverage described the extension as an expansion of the companies’ existing chip partnership rather than a brand-new arrangement, with the extension aimed at “easing concerns” about continuity of supply. That framing matters for investors because Apple devices ship on predictable cycles and require stable upstream sourcing for components that are not easily interchangeable.

Broadcom, which supplies semiconductors and related infrastructure components to multiple device makers, has been positioning its custom chip work as a strategic differentiation. For Apple, retaining a qualified supplier with development expertise can be particularly valuable for chips that require iterative design changes and tight integration with Apple’s system software and product requirements.

Still, the reports do not provide granular details such as the size of the manufacturing commitment, the specific chip families covered by the expanded agreement, or whether the extension includes any new wafer starts, packaging capacity, or process-node transitions. Without that disclosure, it is not possible to quantify how the terms might affect Broadcom’s revenue mix or Apple’s cost structure.

One additional uncertainty is scope. Market coverage indicates Broadcom will continue to develop and supply “a range” of custom chips, but it does not specify whether the 2031 extension covers the same set of products across Apple’s product lines or whether it introduces new categories of chips as Apple’s road map evolves.

What to watch next is whether either company issues a fuller statement in connection with the agreement, such as an investor presentation, a filing, or an earnings call discussion that clarifies capacity, product scope, and any expected timing for deliveries beyond the current program term.